LeMaitre Vascular, Inc. (LMAT) Q4 2022 Earnings Results

Lemaitre Vascular Misses on EPS, Stock Up 1.8%

Lemaitre Vascular's earnings report showed a slight miss on EPS, which may raise concerns among some investors. However, the stock reacted positively, increasing by 1.8%, likely due to management's optimistic outlook on future growth and product development. The lack of revenue data and guidance leaves some uncertainty for investors looking for clearer direction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.25	N/A	-4.58%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management conveyed a cautious optimism about future prospects. They emphasized their commitment to innovation and market expansion.

Management highlighted ongoing efforts to enhance product offerings.

They expressed confidence in long-term growth despite current challenges.

Lemaitre Vascular Misses on EPS, Stock Up 1.8%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Misses on EPS, Stock Up 1.8%

Key numbers

Management commentary